Yahoo Web Search

Search results

    • Maxim Group Lowers Augmedix (NASDAQ:AUGX) to Hold

      ETF DAILY NEWS· 2 days ago

      Maxim Group downgraded shares of Augmedix (NASDAQ:AUGX – Free Report) from a buy rating to a hold rating in a research report report published on Tuesday morning, Marketbeat.com ...

    • Q3 2024 Aytu Biopharma Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 2 days ago

      Mark Oki; CFO; Aytu Biopharma, Inc. Roger Weiss; Moderator; Lytham Partners IR Naz Rahman; Analyst; Maxim Group Presentation Operator Good afternoon, everyone, and welcome ...